key: cord-0869818-mhfhuqbs
authors: Zhang, Kai; Fan, Zhenqiang; Ding, Yuedi; Li, Jinlong; Li, Hao
title: Thiol-sensitive probe enables dynamic electrochemical assembly of serum protein for detecting SARS-Cov-2 marker protease in clinical samples
date: 2021-12-15
journal: Biosens Bioelectron
DOI: 10.1016/j.bios.2021.113579
sha: 77ac952a47dc9a0d967f1158b16d3a0fa75f59bb
doc_id: 869818
cord_uid: mhfhuqbs

The poor situational awareness about the spreading of the virus especially in the underdeveloped regions calls for novel virus assays of low cost and simple operation. Currently, such assays are exclusively restricted to nucleic acid detection. In this investigation, a virus protein serum assay has been proposed in a one-step and reagent-less route. Specifically, in this assay, the main protease of the virus is targeted by a short probe mimicking its substrate. While the probe-protein interaction brings them together, a fluorescent thiol targeting molecule reacts with the free thiol groups on the target protein near the probe, generating a fluorescence signal proportional to the concentration of the target. This induces an electroactive 2D peptide nano-network on the sensing surface only in the presence of the target protein. The sensitivity of the method is enhanced through potential electrochemical scanning during incubation with serum samples. The successful detection of the virus marker protein in the serum of the infected patients encourages further development of incorporation of this method into clinical practice.

1 COVID-19 vaccination is successfully an ongoing process in many 2 countries;(Krammer 2020) still, some impoverished regions are in dire need of this 3 vaccine. (Sbarra et al. 2021 ) So, large scale surveillance becomes the first line of 4 defense in combating the virus, providing all the important situation awareness. (Hozé 5 et al.) In this data network of global awareness, the poorly developed regions usually 6 have a weak link. The simple, fast, one-step, reagent-less and low-cost SARS-Cov-2 7 assays are urgently required to provide effective coverage for these regions. The 8 current gold standard, the nucleic acid test, needs several amplification steps, 9 introducing human errors since the medical staff works under stress. (Basile et al. 2020 ) 10 On the other hand, the traditional antibody-based assays seem to have fewer chances 11 of replacing the DNA test. This is due to the relatively high cost of biologically 12 produced antibodies and enzymes. (Weinstein et al. 2020 ) Hence, researchers have 13 developed artificial targeting molecules such as aptamers and small molecular drug 14 leads, but these have rarely been applied in clinical practice. The less strong binding 15 affinity (Kalra et al. 2018) of these targeting molecules than antibodies is the main 1 reagent is required to mark the surface captured target protein. But we aim to achieve 2 a reagent-less detection route. For this, the reactivity of amino acid side chains is 3 considered. These are two cysteine residues with free thiol groups (Zhang et al. 2020) 4 located near the substrate-binding pocket of the target protein. The 5 substrate-mimicking probe is extended by a recently developed fluorescent "signal 6 on" detector molecule. (Liu et al. 2016 ) This is a recently developed "signal-on" probe, 7 which has a maleimide group that can react with thiol to recover the quenched 8 fluorescence of the conjugated 1,8-naphthalimide. This fluorophore can be activated 9 by visible light, avoiding UV radiation that can lead to large background interference.

This molecule forms covalent bonding with the free thiol groups, leading to "lighting".

In this way, using one probe alone, not only the target protein is irreversibly attached 12 to the sensing surface, but the covalent attachment also generates a signal in 13 proportion to the amount of surface captured protein molecules. This covalent 14 attachment is indispensable in clinical application, as it allows thorough denaturing on 15 the sensing layer to remove the non-specific interfering species. High robustness can 16 therefore be achieved at the same time when complicated assaying steps involving 17 additional reagents are also not needed.

But the sensitivity may not be sufficient in this design, while additional biosensing 19 reagents are avoided to simplify the assay maximally. Hence, the well-established 20 electrochemical pre-treatment in mass spectrometry/chromatography protein analysis 21 can be employed. In this, a simple potentiostat module can electrochemically reduce so that no extra step is required before collecting signal readout. Thus, a low-cost, 12 one-step, reagent-less bio-assay using only synthesizable simple molecules are 13 developed, enabling not only antibody-like strong targeting of the virus marker 14 protein, but also reasonable signal amplification, using the interfering species in the 15 serum as signal amplifier. The peptide probe (sequence shown in Scheme S1) and the ferrocene tagged control Second Hospital. The patients were randomly picked from the sample bank, and since 7 only the marker protein in their blood samples were under concern, the past medical 8 history of the patients were not disclosed. These 9 patients were incidentally all male, 9 aged from 21-56. And the sample bank collected these samples from a wide area not 10 restricted to Nanjing, during the outbreak in the first half of 2020. The blood samples 11 were stored in heparin vial, before testing, the samples were centrifugated for 15 min 12 at 2500 RPM, and then the supernatant was collected. Strictly adhering to the safety 13 regulations, all experiments were carried out in the enclosed area of the laboratory. was cut into small pieces to fit the small cuvette for fluorescence measurement. In 18 order to fix the probe, the ITO glass slide was continuously immersed in dd water, 19 ethanol and methanol, and subjected to bath ultrasonic treatment to remove any 20 organic impurities absorbed on the surface. The end of the probe (Scheme S1) 21 contained a 16-phosphohexadecanoic acid residue (Sigma-Aldrich), which could 22 self-assemble on the ITO surface. To start this process, drop the probe stock solution 23 onto the newly cleaned glass slide, and then mark the area covered by the stock 24 solution drop with a marker pen. Then the self-assembly process was carried out for 13 Then the fluorescent signal of covalent bonding between the probe and the target 14 protein can be directly studied. But before that step, the surface density of the probe 15 molecules should be studied. To this end, the fluorescent thiol-targeting molecules is 16 swapped out, and replaced by an electrochemical reporter molecule, ferrocene. The 17 result is shown in Figure S1 , which is the cyclic voltammetric I-V curve recorded on 18 the ferrocene-tagged probe modified sensing surface. While knowing the potential Since only correctly oriented protein can put its free thiol groups in contact with the 7 probe. And only the probe-target molecular recognition can induce the correct 8 orientation effectively. Figure S4a , the background signal is negligible. This is because the 2 probe is peptidomimetic but not the amino acids that can react with the serum protein, 3 and the Thiol group is also absent in the probe. As a proof, the solution for thorough 4 rinsing is collected after the slide has been incubated for long time with the blank 5 serum. The solution is centrifugated; and the parameter is set so that normally, 6 proteins won't be fractionated. But this time there is sediment, which, if collected and 7 dried on a working electrode, can generate the characteristic electrochemical response 8 of aromatic amino acid oxidation ( Figure S4b ). This result confirms that the 9 electrochemical scanning is able to cross-link proteins to form larger oligomers, but 10 they cannot anchor to the surface slide. In Figure S4c , the time course of detecting the 11 target protease at relative high and extremely diluted concentrations are studied, and it 12 can be concluded that 50 min incubation under electrochemical agitation is the 13 optimal for maximizing the signal difference between different concentrations. As 14 shown in Figure S4 , the peptide probe can work specifically for SARS-Cov-3CL 15 protease. 

Accuracy amidst ambiguity: false positive 11

SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low

Local Burden of Disease Vaccine Coverage, C., 2021. Mapping routine measles vaccination in 4 low-and middle-income countries

In-Source Reduction of Disulfide-Bonded Peptides Monitored by 6

Platelet-driven formation of interface peptide 11 nano-network biosensor enabling a non-invasive means for early detection of Alzheimer